AstraZeneca PLC - Cambridge, UK-based pharmaceuticals firm - Announces wholly owned subsidiary AstraZeneca Finance prices a three tranche global bond offering totalling $2.25 billion on February 28. Expects offering to close on March 3. Says the notes issued by AstraZeneca Finance LLC and fully and unconditionally guaranteed by AstraZeneca are $1.1 billion of fixed rate notes with a coupon of 4.875%, maturing March 3 2028, $650 million of fixed rate notes with a coupon of 4.900%, maturing March 3 2030, and $500 million of fixed rate notes with a coupon of 4.875%, maturing March 3, 2033. Expects to use the net proceeds of the offering for general corporate purposes, which may include the refinancing of existing indebtedness.

Current stock price: 10,815.57 pence

12-month change: up 16%

Copyright 2023 Alliance News Ltd. All Rights Reserved